The Relationship Between Health Insurance Status and Diabetic Retinopathy Progression

被引:0
|
作者
Guo, Yian [1 ,2 ]
Copado, Ivan A. [1 ,3 ,4 ]
Yonamine, Sean [1 ,5 ]
Ma, Chu Jian [1 ,6 ]
McLeod, Stephen [2 ,7 ]
Arnold, Benjamin F. [1 ,2 ]
McCulloch, Charles E. [8 ]
Sun, Catherine Q. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Ophthalmol, 490 Illinois St,5th floor, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, FI Proctor Fdn, San Francisco, CA USA
[3] Univ Calif San Diego, Viterbi Family Dept Ophthalmol, La Jolla, CA USA
[4] Univ Calif San Diego, Shiley Eye Inst, La Jolla, CA USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[6] Univ Illinois, Dept Ophthalmol & Visual Sci, Illinois Eye & Ear Infirm, Chicago, IL USA
[7] Amer Acad Ophthalmol, San Francisco, CA USA
[8] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
来源
OPHTHALMOLOGY SCIENCE | 2023年 / 4卷 / 03期
基金
美国国家卫生研究院;
关键词
Diabetic retinopathy; Health insurance; Mediation analysis; MEDIATION ANALYSIS; UNITED-STATES; DISPARITIES; POPULATION; CARE; DISADVANTAGE; SAS;
D O I
10.1016/j.xops.2023.100458
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To determine if baseline diabetic retinopathy (DR) severity mediates the relationship between health insurance status and DR progression. Design: Retrospective cohort study. Subjects: Seven hundred sixteen patients aged > 18 years with a diagnosis of type 1 or 2 diabetes mellitus, and a diagnosis of nonproliferative DR (NPDR) were identified from the electronic health record of a tertiary academic center between June 2012 and February 2022. Methods: NPDR severity at baseline was the proposed mediator in the relationship between insurance status and proliferative DR (PDR) progression. Logistic regression was used to determine the association between insurance status and NPDR severity at baseline, and Cox proportional hazards regression was used to assess the association between insurance status and time to PDR progression. To analyze the mediation effect of NPDR severity at baseline, a counterfactual approach, which decomposes a total effect into a natural direct effect and a natural indirect effect was applied. Main Outcome Measures: Time to progression from first NPDR diagnosis to first PDR diagnosis. Results: Of the 716 patients, 581 (81%) had Medicare or private insurance, 107 (15%) had Medicaid, and 28 (4.0%) were uninsured at their baseline eye visit. Uninsured or Medicaid patients had a higher proportion of moderate or severe NPDR at their baseline eye visit and a higher proportion of progression to PDR. After adjusting for confounders and NPDR severity at baseline, patients who were uninsured had significantly greater risk of progression to PDR compared with that of patients with Medicare/private insurance (hazard ratio [HR]: 2.63; 95% confidence interval [CI]: 1.10-6.25). Patients with Medicaid also had an increased risk of progression to PDR compared with that of patients with Medicare/private insurance, although not statistically significant (HR: 1.53; 95% CI: 0.81-2.89). NPDR severity at baseline mediated 41% of the effect of insurance status (uninsured vs. Medicare/private insurance) on PDR progression. Conclusions: Patients who were uninsured were more likely to have an advanced stage of NPDR at their baseline eye visit and were at significantly greater risk of progression to PDR compared with patients who had Medicare or were privately insured. Mediation analysis revealed that differences in baseline NPDR severity by insurance explained a significant proportion of the relationship between insurance status and DR progression. Financial Disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article. Ophthalmology Science 2024;4:100458 2023 by the American Academy of Ophthalmology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Relationship between Health Insurance Status and the Pattern of Traditional Medicine Utilisation in Ghana
    Gyasi, Razak Mohammed
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [2] Association between insurance status and prevalence of diabetic retinopathy in patients with diabetes in the United States from 2011 to 2020
    Khorsandi, Jordan
    Kraversky, Daniel
    Martinyan, Jack
    Parekh, Prashant
    Castro, Grettel
    Barengo, Noel
    PRIMARY CARE DIABETES, 2025, 19 (01) : 46 - 52
  • [3] The relationship between the markets for health insurance and medical malpractice insurance
    Karl, J. Bradley
    Born, Patricia H.
    Viscusi, W. Kip
    APPLIED ECONOMICS, 2016, 48 (55) : 5348 - 5363
  • [4] The relationship of central corneal thickness with the status of diabetic retinopathy
    Canan, Handan
    Sahinoglu-Keskek, Nedime
    Altan-Yaycioglu, Rana
    BMC OPHTHALMOLOGY, 2020, 20 (01)
  • [5] The relationship of central corneal thickness with the status of diabetic retinopathy
    Handan Canan
    Nedime Sahinoglu-Keskek
    Rana Altan-Yaycioglu
    BMC Ophthalmology, 20
  • [6] The Relationship Between Diabetic Retinopathy and Systemic Factors
    Demir, Ayse Keyser
    Alirn, Sait
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2014, 5 (06) : 530 - 536
  • [7] Relationship between Glycemic Control and Diabetic Retinopathy
    Yun, Woo-Jun
    ANNALS OF GERIATRIC MEDICINE AND RESEARCH, 2010, 14 (04): : 234 - 241
  • [8] Is there a relationship between diabetic retinopathy and vitamin D?
    Usalp, Zuhat Onur
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14 (04): : 332 - 335
  • [9] Relationship between Biochemical Pathways and Non-Coding RNAs Involved in the Progression of Diabetic Retinopathy
    Mrowicka, Malgorzata
    Mrowicki, Jerzy
    Majsterek, Ireneusz
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [10] Relationship between diabetic retinopathy microalbuminuria and other modifiable risk factors
    Chawla, Shubhaa
    Trehan, Siddhant
    Chawla, Aastha
    Jaggi, Shalini
    Chawla, Rajeev
    Kumar, Vinay
    Singh, Depender
    PRIMARY CARE DIABETES, 2021, 15 (03) : 567 - 570